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ABSTRACT
Structural properties of single j DNA treated with
anti-cancer drug cisplatin were studied with mag-
netic tweezers and AFM. Under the effect of low-
concentration cisplatin, the DNA became more
flexible, with the persistence length decreased sig-
nificantly from ~52 to 15nm. At a high drug concen-
tration, a DNA condensation phenomenon was
observed. Based on experimental results from
both single-molecule and AFM studies, we propose
a model to explain this kind of DNA condensation
by cisplatin: first, di-adducts induce local distortions
of DNA. Next, micro-loops of ~20nm appear through
distant crosslinks. Then, large aggregates are
formed through further crosslinks. Finally, DNA is
condensed into a compact globule. Experiments
with Pt(dach)Cl2 indicate that oxaliplatin may
modify the DNA structures in the same way as cis-
platin. The observed loop structure formation of
DNA may be an important feature of the effect of
platinum anti-cancer drugs that are analogous to
cisplatin in structure.
INTRODUCTION
Cisplatin [Pt(NH3)2Cl2] is one of the most widely used
anti-cancer drug especially to treat testicular, head, neck,
non-small-cell lung and cervical cancers (1). It is generally
believed that the cytotoxicity of cisplatin derives from its
adduct with DNA. In aqueous solution, the two chloride
ions dissociate from the central platinum, and two water
molecules or hydroxide ions locate there, transforming
cisplatin to an active state (2,3). When the aqueous cis-
platin reacts with DNA, its water molecules are easily
substituted by the N7 atoms of guanine or adenine to
form both mono-adduct and di-adduct (4,5). The biologi-
cal eﬀects of cisplatin on DNA are quite complicated.
According to previous studies, cisplatin–DNA adducts
may interact with cellular proteins in several modes, for
instance, hijacking transcription factors to block DNA
transcription, blocking oﬀ DNA polymerase or RNA
polymerase bypassing (6,7).
The cisplatin–DNA adducts mainly contain intrastrand
crosslinks: 65% 1,2-d (GpG), 25% 1,2-d (ApG), 5–10%
1,3-d (GpNpG), as well as a small portion of interstrand
crosslinks (8). X-ray structure of a 12-bp double-strand
DNA containing a single 1,2-d(GpG) adduct reveals that
the adduct bends the double helix 508 towards the major
groove. In addition, there is a 308 dihedral between the
two adjacent guanines (9,10). The NMR solution structure
of the same platinated DNA was also resolved, with a
bending angle of 788, and a 258 unwinding of the double
helix (11). In brief, cisplatin molecules are able to bind to
DNA target, make intrastrand and interstrand crosslinks,
and distort severely the double helix towards the major
groove as well as induce a partial unwinding near the
adduct sites (12).
Over the past decade, single-molecule techniques have
been developed as helpful methods to measure the proper-
ties of DNA–ligand-binding and DNA–protein interac-
tion. For instance, Hatch et al. (13) have studied the
salt-dependent stabilization of partially open  -phage
DNA by Escherichia coli SSB protein using magnetic
tweezers. Williams et al. have done a lot of work on
the interaction between DNA and proteins (i.e. HIV-1
nucleocapsid protein, T4 gene 32 protein, HMGB) by
single-molecule stretching experiments using optical twee-
zers (14–16). Eﬀects of DNA-binding proteins such
as HU, IHF and H-NS on DNA mechanical properties
have also been measured with magnetic tweezers (17–19).
Besides, in recent years, some signiﬁcant ﬁndings about
ionic eﬀects and ligand binding to DNA have been
made with these single-molecule techniques. Diﬀerent
DNA-binding modes of small molecules have been
observed by the single-molecule force spectroscopy (20).
Through the measurement of WLC (worm-like chain)
behavior of   DNA, it is revealed that multivalent ions
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6 reduce the persistence length of DNA
to 25–30nm, obviously much below the normal value of
45–50nm in monovalent salt (21). Also, DNA intercala-
tors such as EtBr and YOYO-1 lead to a similarly
decreased DNA persistence length (22). Furthermore,
step-wise DNA condensation under the interaction of
multivalent ions was revealed in single-molecule experi-
ments (23). In addition to optical and magnetic tweezers,
AFM is another widely used technique for DNA investi-
gation due to its high-quality image resolution, and it has
also been applied to drug discovery (24).
Previously, there were several studies exploring the
eﬀects of cisplatin on the mechanical properties of
DNA. Gaub et al. (25) have used single-molecule force
spectroscopy to measure the structural changes of DNA
induced by cisplatin. Their results revealed that the B-S
transition was very sensitive to the binding of cisplatin.
Besides, the separation of the double helix was inhibited
as a result of interstrand crosslinks. In addition to B-S
transition, the elasticity of the DNA molecules has also
been studied by single-molecule experiment qualitatively
(26). The force versus extension curve was observed to be
altered. However, the authors did not give out the persis-
tence length and contour length. Besides, there were no
results about the eﬀect of cisplatin concentration, or about
the change with time.
In the current work, we employed magnetic tweezers
technique and AFM to systemically study the eﬀect of
cisplatin on the mechanical and structural properties of
  DNA. Single-molecule experiments using a magnetic
tweezers showed that cisplatin may reduce the persistence
length of DNA from  52nm to less than 20nm. AFM
imaging revealed that the much reduced persistence
length resulted from the formation of many local kinks
on DNA. Besides, WLC ﬁtting of force versus extension
curve and AFM imaging both revealed that DNA contour
length was basically not aﬀected. At high cisplatin concen-
trations, we observed with the magnetic tweezers that the
DNA extension gradually shortened under low force
( 1 pN) and this shortening was irreversible even at 20
pN stretching force. AFM imaging identiﬁed the mecha-
nism for this kind of DNA condensation: ﬁrst, micro-
loops by long distance crosslinks were formed due to
DNA thermal ﬂuctuation, then large aggregates were
formed, and ﬁnally the DNA molecule was condensed
into a compact globule. We think the formation of this
kind of loops by distant crosslinks is an important prop-
erty of DNA–cisplatin interaction. At last, Pt(dach)Cl2
was also studied for comparison. It was found that it
interacted with DNA in a similar manner as cisplatin.
We believe the current study will be helpful for under-
standing more deeply the eﬀects of cisplatin on mechanical
and structural properties of DNA.
MATERIALS AND METHODS
Chemical reagents
Cisplatin was purchased from Sigma-Aldrich (USA),
Pt(dach)Cl2 was obtained from the Institute of Precious
Metal in Kunming of China.   DNA for magnetic
tweezers experiment was from New England Biolabs. It
was isolated from   phage c1857 S7, 48502bp in length,
with 12-nt single-strand overhanging at both ends. The
catalog number was N3011. The 12-nt oligomers with
modiﬁcations (see below) and   DNA for AFM imaging
were from the Sino-America Biotechnology Company in
Shanghai of China. For the magnetic tweezers experi-
ments, we used streptavidin-coated magnetic polystyrene
microspheres with a diameter of 2.8mm from Dynal
Biotech (Norway). Solutions were made with 18.2 M
deionized water puriﬁed through the Milli-Q Water
Puriﬁcation System (Millipore Corporation, France).
AgNO3 and all the other chemicals are all reagent grade.
Invitro platination
Cisplatin was converted to diaqueous derivative by react-
ing with two equivalents AgNO3 in solution at room tem-
perature for 24h in the dark. Then the mixture was
centrifuged at 13 000rpm for 10min twice to remove the
AgCl precipitation thoroughly (27). Reactive Pt(dach)Cl2
solution was prepared in the same way. DNA was incu-
bated with platinum solution of various ﬁnal concentra-
tions at 37
8C in the dark.
DNA construction for single-molecule study
The two 12-nt single-stranded ends of   DNA molecules
were annealed respectively with two 12-nt chemically
labeled single-stranded oligomers, 30-biotin-cccgccgctgga
and 30-digoxygenin-tccagcggcggg, according to the stan-
dard procedures (28). Afterwards, streptavidin-coated
paramagnetic polystyrene microspheres with a diameter
of 2.8mm were bound to DNA through interaction with
biotin (29). DNA molecules carrying a microsphere at
one end and digoxygenin at the other end were then
ready for use.
Magnetictweezers setup
A home-built transverse magnetic-tweezers system was
employed in our single-molecule experiments (Figure 1).
A single DNA molecule with a paramagnetic microsphere
at one end, as constructed above, was ligated to the
polished edge surface, covered by anti-digoxygenin, of
the sandwiched cover glass in the ﬂow cell. With single
biochemical links at its two extremities, the DNA
Figure 1. Experimental setup for transverse magnetic tweezers. The
ﬂow cell is constructed by sandwiching a 0.17mm thick cover glass
between two slides. The applied force is controlled by changing the
distance between the magnetic microsphere and the magnets. DNA
can also be rotated by rotating the magnets.
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was pulled by permanent magnets about 5mm away at
the right side of the ﬂow cell. Applied force can only be
altered by changing the distance between the magnets and
microsphere through moving the magnets. Besides, rota-
tion of the microsphere could be achieved by rotation of
the magnets. The ﬂow cell was placed in an inverted
microscope (IX71, Olympus, Japan) which was employed
to observe the movement of the microsphere relative to the
polished edge surface of the cover glass in the ﬂow cell. A
CCD camera (DV885, Andor Technology) was used to
record the position of the microsphere in real-time.
DNA extension was determined as the distance between
the microsphere and the polished edge surface of the cover
glass by a homemade program. The applied force was
calculated according to the position ﬂuctuations of
the microsphere in the direction perpendicular to the
DNA extension (30).The buﬀer used in all the single-
molecule experiments was 10mM Tris–HCl, pH 7.5,
with 5mM NaCl.
Single-molecule measurement
We carried out the single-molecule experiments with the
magnetic tweezers in the following steps.
(i) Ligated the microsphere-bound DNA molecules to
the polished edge surface of the cover glass in ﬂow cell.
Then rinse the cell with buﬀer to clean out the free
particles.
(ii) Grabbed a ligated particle and conﬁrm that it was
connected to the surface through a single DNA molecule.
First, the extension of the   DNA should be close to 16.5
mm under a high tension (20 pN). Next, we set the applied
force to about 0.2 pN, and rotated the particle for 400
turns. If no shortening was observed, there should be
only one DNA molecule ligated. Then, for further conﬁr-
mation, a force versus extension measurement was
employed. By ﬁtting the data with the WLC model, a
persistence length at 52 2nm and a contour length at
16.5 0.5 mm should be obtained (31). In each experi-
ment, a molecule grabbed was checked to be single in
the above way.
The persistence length and contour length of DNA were
obtained by ﬁtting the force versus DNA extension curves
with the WLC model (32),
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where F is the stretching force, L is the DNA extension,
A and L0 are the persistence length and the contour length
of the DNA molecule, respectively. The coeﬃcients used
are a2= 0.5164228, a3= 2.737418, a4=16.07497,
a5= 38.87607, a6=39.49944 and a7= 14.17718.
(iii) Carried out the WLC behavior measurement. First,
ﬂow cisplatin at a given concentration to the ﬂow cell.
During this process, DNA was kept stretched under 20
pN force. Next, adjust the applied force. Then record
the position of the microsphere in real-time. After the
DNA extension becoming stabilized, perform force
versus extension measurement (33).
For measuring the change of the DNA persistence
length with time in the presence of cisplatin, after the
DNA was tethered successfully to the surface, and con-
ﬁrmed to be a single molecule, 77mM cisplatin was
slowly injected to the ﬂow cell. Then we repeated the
force versus extension measurement at diﬀerent times
during a total time interval of more than 12h. DNA was
kept stretched under high tension between two consecutive
measurements.
(iv) Carried out DNA shortening measurement. After
the DNA ligation, and conﬁrmed to be single molecule,
770mM cisplatin was injected to the ﬂow cell while 20 pN
force was used to keep DNA under high tension.
Afterwards, we adjusted the magnetic force to a lower
value so that the DNA molecule could exist with a high
ﬂexibility. DNA extension was recorded in real-time. In
control experiment, DNA was always stretched by a force
of 20 pN. By comparing the diﬀerent results at low and
high forces, the inﬂuence of DNA thermal ﬂuctuation on
its interaction with cisplatin may be seen.
AFM samplepreparation and imaging
Free unmodiﬁed   DNA was incubated with cisplatin fol-
lowing the standard procedure described above. All
manipulations were carried out in 10mM Tris–HCl, pH
7.5. The concentration of DNA was 50ng/ml.
To study the change of DNA conﬁguration with time by
AFM imaging, a 10ml solution of 50ng/ml DNA and
77mM cisplatin (the cisplatin: nucleotide ratio is about
0.5) or 770mM cisplatin (the cisplatin:nucleotide ratio is
about 5) was incubated at 378C in the dark. An aliquot of
1ml was taken out at the indicated times and diluted to a
DNA concentration of 1ng/ml for AFM scanning. In the
study of Pt(dach)Cl2, the experiments were performed in
the same way as above.
We have employed two diﬀerent techniques to adsorb
DNA molecules onto mica surface.
(i) To stretch DNA on mica to an extended morphology
for AFM imaging, we used one kind of molecular comb-
ing method: one freshly cleaved mica was immobilized on
an inclined plane, then a 10ml droplet with 1ng/ml DNA
and 1mM Ni
2+ was deposited on the top of the surface
(34). After the droplet ﬂowed from the surface top to
bottom, the extra solution was absorbed away tenderly
with a micropipette.
(ii) To adsorb DNA on mica surface with their natural
conﬁguration (35), samples were prepared by depositing
a1 0 ml droplet of 1ng/ml DNA in 10mM Tris–HCl
(pH 7.5) and 5mM Mg
2+ onto freshly cleaved mica.
After 5min, mica surface was washed with 200ml Milli-
Q ﬁltered water for several times and blown dry in a gentle
stream of nitrogen gas.
The imaging was performed in air with a multi-mode
AFM with nanoscope IIIa controller (Digital Instruments,
Santa Barbara, CA, USA) in the tapping-mode. Silicon
probe RTESP14 from Veeco (America) was employed,
with a resonance frequency of 315kHz. ‘E’ scanner was
used. The scan frequency was 1Hz per line, and the scan
1402 Nucleic Acids Research, 2009, Vol. 37, No. 5size was from 1 to 5mm. DNA tracing and measurement
were done semi-automatically using Image J software.
RESULTS
WLC elastic behavior
The WLC model describes the elastic behavior of duplex
DNA under tension, where DNA is treated as a
semi-ﬂexible chain, and its ﬂexibility is reﬂected by the
persistence length (32). The contour length is another
parameter, corresponding to the maximum DNA length
when it is inextensible under high tension. For a single  
DNA molecule, previous experiments revealed a persis-
tence length of 45–50nm (21) and a contour length of
about 16.5mm. Both static bending and thermally induced
dynamic bending may result in the change of persistence
length, and Yan et al. (36) have systemically reported the
theoretical modeling results of DNA persistence length
reduction by DNA-binding proteins as well as intercala-
tors with various binding modes.
In our experiment, we ﬁrst recorded the extension
change of DNA with time after cisplatin was added.
Figure 2A shows that at 77mM cisplatin, the DNA exten-
sion gradually shortens with time, and after about 4h, it
reaches a steady state. Then we performed the force versus
extension measurements. Figure 2B shows typical results
for DNA alone (as a control), DNA interacting with
77mM cisplatin and with 15.4mM cisplatin. From the
WLC ﬁtting according to Equation 1, the obtained persis-
tence lengths are 52.4, 15.0 and 25.0nm, respectively.
Their contour lengths obtained from the ﬁtting are all
close to 16.5mm (16.4, 16.6 and 16.6mm, respectively). In
addition, a force versus extension measurement was also
performed for DNA with 46.2mM cisplatin. The ﬁnal per-
sistence length is 20.6nm, between that for 77 and 15.4mM
cisplatin. It is clear that when DNA was treated with cis-
platin for a plenty of time, its persistence length was
decreased, while the contour length showed little
variation.
To further study the decrease of DNA persistence
length with time, we introduced 77mM cisplatin to DNA
in ﬂow cell, and repeated measuring the force versus exten-
sion curves at diﬀerent times. From ﬁtting of the curves
with Equation 1, we obtained contour lengths that did not
change much with time (data not shown). The persistence
length, however, decreased rapidly during the ﬁrst 4h and
then became stabilized (Figure 2C), with the ﬁnal value
( 14.9nm) being in agreement with the result of direct
measurement after DNA extension becoming stabilized
(Figure 2B). This behavior of persistence change is not
diﬃcult to understand: at the beginning, there are quite
a lot of binding sites on DNA for cisplatin, thus the
number of bound cisplatin molecules increases with
time, resulting in continuous variation of the DNA struc-
ture. After the binding sites are becoming saturated with
cisplatin, cisplatin-binding and thus DNA structure
change are slowed down and ﬁnally stabilized.
As to why cisplatin-binding changes the structure and
persistence length of DNA, we need to consider the bind-
ing mode of cisplatin to DNA. We know cisplatin makes
Figure 2. Single-molecule experiments under low concentration of cis-
platin. (A) After 77mM cisplatin was added to the ﬂow cell, the force
exerted on DNA was adjusted to 1.3 pN, and the end to end distance
was recorded in real-time. After about 4h, DNA extension reaches a
steady state. (B) The force versus extension curves for bare DNA
(black), DNA treated by cisplatin of 77mM (red) and 15.4mM (blue)
after the extension reached the steady states. The lines are the best ﬁts
of the data to Equation 1. (C) The change of persistence length with
time when 77mM cisplatin was added to DNA in the ﬂow cell.
Persistence length was obtained from ﬁtting of the force versus exten-
sion curves to Equation 1 measured at the indicated times. After about
4h, the persistence length reaches a steady state.
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1,3-d (GpNpG) of DNA, as well as a few interstrand
crosslinks, and distorts DNA to the major groove about
508 (9,10). According to Yan et al.’s theory (36), this kind
of local bending will induce a decreased persistence length.
In fact, there are also other DNA-binding ligands capable
of altering DNA persistence length with various binding
modes. For instance, single molecule experiments have
revealed that the minor groove binder distamycin-A, the
major groove binder a-helical peptide, and the DNA inter-
calator EtBr reduce the DNA persistence length to 26.7,
29.4 and 20.7nm, respectively (22). Our present work is
the ﬁrst quantitative report of the eﬀect of cisplatin on
DNA persistence length measured with single molecule
method.
To observe more directly the eﬀect of cisplatin on DNA
structure, we then used AFM scanning to image DNA in
the presence of 77mM cisplatin.
By using the method as described in the Materials and
methods section,   DNA molecules could be stretched
linearly on the mica surface as shown in Figure 3A. This
indicates that the force exerted by the withdrawing inter-
face between mica and the liquid is strong enough. In the
presence of cisplatin, after an incubation of 6h, some local
kinks appeared (Figure 3B), corresponding to the forma-
tion of adducts which bend DNA. This kind of DNA
morphology is in agreement with the single-molecule
observation which revealed a reduced persistence length.
After 12h, DNA coiling became more serious (Figure 3C
and D). When observing carefully, we could see many tiny
globules with a typical size of  20nm and an average
height of  1nm (note that a single dsDNA strand on
mica surface is about 0.5nm in height). We assume that
this kind of structures are micro-loops, formed in a mode
diﬀerent from the crosslinks of adjacent GpG, ApG or
GpNpG bases. The identiﬁcation of this kind of structures
and mechanism of their formation will be discussed later.
Actually, we have also scanned   DNA molecules incu-
bated with cisplatin of lower concentrations (1 and
15.4mM) for 12h. We observed that DNA was compara-
tively extended with only several local kinks under the
condition of 1mM cisplatin, while the DNA took a
shape like that in Figure 3C with 15.4mM cisplatin (data
not shown).
Furthermore, to study the change of DNA contour
length after interaction with cisplatin by AFM, we carried
out experiments with 2kb DNA of which the contour was
easy to trace (37). These 2kb double-strand fragments
were produced by PCR using   DNA as a template and
50-tggtcgttcagggttgtcgga-30 and 50-cgccttgccctcgtctatgta-30
as primer sequences, then puriﬁed by gel extraction.
Only linear DNA without loops on mica surface were
measured. As the theoretical contour length of 2kb
DNA is  680nm, we regarded DNA molecules much
less than 680nm as incomplete ones that were not included
in the length statistics. The average contour lengths of the
free and cisplatin-treated DNA on mica surface were 656.8
and 653.1nm, respectively (Figure 4). It is clear that cis-
platin just bends DNA backbone, and does not aﬀect the
contour length much, in agreement with the results for  
DNA obtained with magnetic tweezers.
DNA shortening
DNA-shortening eﬀect has been previously reported in
literatures studying cisplatin–DNA interaction. In one
case, molecules of 260-bp DNA incubated with cisplatin
in the dark at 378C for 24h was scanned by AFM and
shown to have a 30% decrease in contour length (38).
Also, in a quite early work in 1978, EM pictures revealed
a DNA shortening phenomenon when a high concentra-
tion of the drug was used (39). Although this shortening
eﬀect has been observed, a reasonable explanation was
still lacking. Moreover, this kind of structure changes is
rarely mentioned in literatures studying the binding mode
of cisplatin to DNA. Here we used both single-molecule
technique and AFM imaging method to study the
mechanism of DNA shortening that occurred at high cis-
platin concentration.
First, we incubated   DNA with cisplatin of high con-
centration ( 513mM) for 12h. Then the solution was
introduced into the ﬂow cell. After DNA ligation, we
stretched the DNA by the magnetic tweezers. It was
observed that almost all DNA molecules exhibited sur-
prisingly short lengths (data not shown). Even the highest
force (20 pN) could only stretched most of them to lengths
of less than 7mm. The longest one we observed was
11.4mm, still much less than   DNA’s contour length
(16.5mm). These results are diﬀerent from those observed
in the previous experiments at low cisplatin concentration,
where the contour length was almost invariable. Thus we
believe diﬀerent new structures may be formed at high
drug concentration.
Figure 3. AFM images of   DNA alone or incubated with 77mM
cisplatin at diﬀerent times. (A) Unmodiﬁed DNA in the absence of
cisplatin. The DNA was stretched on mica surface (see Materials and
methods section). (B) In the presence of cisplatin, 6h incubation.
(C) and (D) 12h incubation. DNA coiling became more serious, accom-
panied by formation of tiny structures (micro-loops, as indicated by
arrows). All scale bars are 500nm.
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tatively, we then carried out another experiment. As
described in the Materials and methods section,   DNA
was constructed in the ﬂow cell. After drug addition with a
ﬁnal concentration 770mM, a low force ( 1 pN) was used
to stretch the single DNA molecule. At this low force,
DNA was in a ﬂexible state. Under this condition, we
observed that the DNA extension decreased rapidly to
less than 3mm in about 100min due to its interaction
with cisplatin (Figure 5A). Note that the DNA had been
checked to be intact after ligation according to the reason-
able persistence length and contour length. However, its
extension under  1 pN was less than the normal value of
14mm at the beginning. This should be due to the fact that
cisplatin–DNA interaction already occurred to some
extent during the process of drug ﬂowing and force adjust-
ment. The experiment was repeated several times while the
results were similar.
We found that the shortening process as shown in
Figure 5A was irreversible: even a high force (20 pN)
could only stretch the condensed DNA to a maximum
of  11mm, much less than its full contour length of
16.5mm. As a control, we repeated the experiment while
using a high force (20 pN) from the beginning. In this case,
we observed that the DNA was unable to shorten in the
presence of the high concentration cisplatin (Figure 5B).
The above results indicate that the new structures that
cause DNA shortening cannot be formed at a high stretch-
ing force (20 pN). But once they are formed at a low force,
they cannot be disrupted by a 20 pN high stretching force.
To determine the new DNA structures that formed
accompanying DNA shortening, AFM scanning of
DNA was carried out at the cisplatin concentration of
770mM. The measurements were carried out at diﬀerent
incubation times.
After an incubation of 1h, DNA became curled
(Figure 6A), in contrast with the extended structure
on mica surface in the absence of drug (Figure 3A).
Actually, this kind of coiling was diﬀerent from that
observed at low cisplatin concentration (77mM,
Figure 3). Here, besides local distortions such as kinks,
local condensations were also presented, as indicated
Figure 4. (A) AFM image of free 2kb DNA adsorbed onto mica surface. (B) AFM image of 2kb DNA treated by 15.4mM cisplatin for 1h. All scale
bars are 500nm. To avoid the inﬂuence of molecular combing on DNA length, samples were made by adsorption with Mg
2+ and without combing
according to the second technique for preparing AFM samples as indicated in Materials and methods section. (C, D) Distribution of lengths
measured for free DNA molecules and molecules treated by 15.4mM cisplatin. The mean contour lengths are 656.8   31.5nm (average of 108
molecules) and 653.1   41.0nm (average of 111 molecules), respectively, for the two cases of free and cisplatin-treated DNA.
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coiled more and more compactly, possessing more and
more local structures (Figure 6B and C). After an incuba-
tion of 6h or longer, the DNA molecules took a shape
that was a collection of small aggregates (Figure 6D and
E). Finally, after an incubation of 12h, DNA was con-
densed to a globule with a typical height of  6nm and a
width of  100nm (Figure 6F).
To better understand the change of DNA structures,
we also carried out experiments with the method of natu-
rally adsorbing DNA onto mica surface by Mg
2+, without
combing. Mg
2+ provides weak adsorption between DNA
and mica, thus DNA can diﬀuse in 2D on the surface and
get to equilibrium state ﬁnally (40). It is a useful way to
observe DNA molecules without strong inﬂuence from the
surface. The AFM pictures are presented in Figure 7. By
comparing the results of molecular combing with natural
adsorption, we ﬁnd that: (i) for DNA with local kinks at
Figure 5. Single-molecule experiments under high cisplatin concentra-
tion (770mM). (A) A typical variation of the DNA extension. The
external force exerted on the DNA was  1 pN. The sharp decrease
corresponded to the time of drug ﬂow. (B) Control experiment where
DNA was kept stretched by a high force (20 pN) close to its contour
length. Although 770mM cisplatin was added, DNA hardly shortened.
Figure 6. AFM images of DNA incubated with 770mM cisplatin.
(A) Incubation of 1h, the arrows indicate the local condensations;
(B) 2h; (C) 4h; (D) 6h; (E) 8h and (F) 12h. All scale bars are 500nm.
Figure 7. AFM images of   DNA adsorbed naturally onto mica surface
by 5mM Mg
2+.( A) Untreated (free) DNA. (B) DNA treated by 77mM
cisplatin for 6h. (C) DNA treated by 770mM cisplatin for 1h. (D)
DNA treated by 770mM cisplatin for 6h. All scale bars are 500nm.
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just makes DNA less coiled, without aﬀecting the local
kink structures much (see Figures 3B and 7B); (ii) at
high cisplatin concentrations (770mM) and when DNA’s
morphology becomes more complex (Figures 6A and 7C),
DNA appears, with the natural adsorption method, more
coiled and more compact while showing no more struc-
tures except for local kinks. In combination with the
results from molecular combing (Figure 6A), it can be
conﬁrmed that long-distance crosslinks do exist
(Figure 7C); (iii) at high cisplatin concentrations
(770mM) and for long incubation time (Figures 6D–6F
and 7D), the two methods give similar results because
the DNA structures are too compact to be opened by
molecular combing. In brief, the two AFM methods
may let us obtain similar conclusions about the structural
changes of DNA in the presence of cisplatin.
It is worth mentioning that the experimental results in
the bulk (Figure 6) are somewhat diﬀerent from the single
molecule results (Figure 5) in terms of the condensation
speed. The same concentration of drug makes the DNA
condensate more rapidly in the single molecule experi-
ment. The reason should be that the ratio of cisplatin to
DNA molecules is higher in the latter case.
Effect ofoxaliplatin on DNA structure
To see if the DNA structural changes under the action of
cisplatin as observed above are inducible by another simi-
lar anti-cancer drug oxaliplatin, we next carried out simi-
lar AFM studies with Pt(dach)Cl2. We used Pt(dach)Cl2
instead of oxaliplatin itself in the experiment because it
induces the same adduct structure as oxaliplatin while it
is more active in DNA-binding in vitro.
Oxaliplatin is the third generation of the platinum anti-
cancer drug, which demonstrates anti-tumor activity
in cell lines with acquired cisplatin resistance (41).
Oxaliplatin has a non-hydrolyzable DACH carrier
ligand instead of diammine compared to cisplatin, and
produces the same kind of inter- or intra-strand crosslinks
as cisplatin, with the 1,2-(GpG) adduct bending the
double helix towards the major groove by about 308
(42), somewhat less severe than cisplatin. Here we used
AFM imaging to study the structural modiﬁcation of
DNA by Pt(dach)Cl2 and to see if this kind of platinum
anti-cancer drug analogous to cisplatin in structure altered
the DNA structure in a similar manner as cisplatin.
We incubated DNA with Pt(dach)Cl2 at a concentration
of 77 or 770mM according to the standard procedure.
After an incubation of 12h, AFM imaging was then per-
formed in the same way as for cisplatin. Under the condi-
tion of 77mM drug, DNA looked ﬂexible, with obvious
kinks as well as some tiny globules assumed to be micro-
loops (Figure 8A). When 770mM drug was used, DNA
was condensed into a compact globule (Figure 8B).
Comparing with previous results of cisplatin, it can be
seen that Pt(dach)Cl2 resembles cisplatin in the modiﬁca-
tion of DNA structures. The diﬀerence is that the eﬀect of
Pt(dach)Cl2 is less strong than that of cisplatin.
Comparing Figure 8A with Figures 3C and D, we can
see that DNA is still in a relatively relaxed form after
incubation with 77mM Pt(dach)Cl2 for 12h. Also, the
ﬁnal globules formed by 770mM Pt(dach)Cl2 have a
height of  3nm and a width of  200nm, thus looser
than those formed with 770mM cisplatin ( 6nm height
and  100nm width, Figure 6F).
To investigate the mechanism of Pt(dach)Cl2–DNA
interaction, we further carried out another experiment to
observe the structural evolvement with time. Total 770mM
drug was used. As can be seen, ﬁrst, some kinks of DNA
appeared (Figure 9A). Then the DNA became curled on
the mica surface with several visible micro-globules
(Figure 9B), then the small structures developed to large
aggregates (Figure 9C), and ﬁnally the molecule was con-
densed into a compact globule (Figure 9D), similar to the
DNA condensing process in the presence of cisplatin
(Figure 6).
From the above experimental observations, we come to
the conclusion that Pt(dach)Cl2 induces kinks to DNA
Figure 9. AFM images of DNA incubated with 770mM Pt(dach)Cl2
with diﬀerent times. (A) 1h; (B) 3h; (C) 7h; (D) 12h. The scale bars
are 500nm.
Figure 8. AFM images of DNA incubated with diﬀerent concentrations
of Pt(dach)Cl2 at 378C for 12h. (A)7 7 mM drug. (B) 770mM drug.
DNA condensed to a compact globule with a typical size of  200nm
and a height of  3nm. The scale bars are 500nm.
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of micro-loops and bigger structures in the same way as
cisplatin. The diﬀerence is that the DNA structure changes
induced by Pt(dach)Cl2 are comparatively a little weaker,
in agreement with the adduct’s crystal structure (42).
DISCUSSION
Combining the experimental results obtained with both
single molecule and AFM imaging methods, we propose
a new model for DNA shortening by cisplatin-binding
(Figure 10). As is well known, cisplatin forms both
di-adduct such as GpG, ApG and mono-adduct. In the
latter case, the mono-adduct is still free to bind to other
nucleotides. Since DNA may ﬂuctuate thermally in solu-
tion, bases distant from each other may be brought to
short distances. Thus if one nucleotide possesses a
mono-adduct, a micro-loop might be formed through
binding of the mono-adduct to the other distant nucleo-
tide. This kind of micro-loops should be just what we
observed at 77mM cisplatin (Figure 3C and D). When a
high concentration of cisplatin is used, these small loops
may be further crosslinked, leading to the shortened mor-
phology and ﬁnally the rather compact structure
(Figure 6). According to the above model, it is expected
that crosslinks between diﬀerent DNA molecules may
happen in the same way as internal crosslinks when
DNA concentration is high. Indeed, at the DNA concen-
tration of 50ng/ml as used in our AFM experiments, we
have observed such crosslinks (data not shown). But this
phenomenon should not aﬀect our conclusion about the
eﬀect of cisplatin on DNA structure and condensation.
Theoretical work on loop formation of DNA reveals
that kinks can not only reduce the loop size severely
from 550 to 110bp, but also increase the probability of
loop formation dramatically (43). Therefore, those
di-adducts by adjacent crosslinks may also play an impor-
tant role in promoting the loop formation, explaining why
so many loops formed in our experiments.
Clearly, when the DNA is stretched by a high force,
the thermal ﬂuctuation cannot overcome the tension on
DNA, thus it is expected that the probability is low for
micro-loops to form. This was supported by the control
experiment, where the DNA molecule was kept in a
stretched form and 770mM cisplatin was unable to con-
dense DNA to short length (Figure 5B). The DNA exten-
sion remained almost constant during the whole recording
time, indicating no particular structure was formed.
Similar kind of DNA-shortening eﬀect has been
reported for the DNA-binding protein Fis which bends
DNA in a nonspeciﬁc manner (44). Single-molecule
experiments revealed that the DNA condensation
occurred abruptly when DNA tension was reduced to a
protein-concentration-dependent threshold of less than 1
pN. The authors suggested that the condensation hap-
pened via Fis stabilizing DNA self-crossing generated by
thermal ﬂuctuation. Note that, in their case, 9 pN force
could entirely disentangle the condensed DNA, which is
diﬀerent from our present case where the micro-loops and
big structures formed by cisplatin were diﬃcult to be
opened even under a high tension of about 20 pN.
Actually, the 770mM cisplatin concentration we used is
too high and it is only practical for the in vitro experiment.
We chose to use such a high concentration in order to
accelerate the drug interaction with DNA. According to
our studies, there are mainly two factors that inﬂuence the
formation of loop structures. One is the drug concentra-
tion and the other is the incubation time. We identiﬁed
with AFM that DNA incubated with 15.4mM cisplatin for
even 48h showed no micro-loops except for local kinks
(data not shown). With 77mM cisplatin and an incubation
time of 6h, there were hardly any micro-loops either
(Figure 3B). After an incubation of 12h, quite a lot of
micro-loops were formed, but bigger structures were
still absent (Figures 3C and D). However, with 770mM
cisplatin, even 1h incubation time could produce quite a
lot of new structures (Figure 6A).
From our observations, it is obvious that the thermal
ﬂuctuation of DNA is quite important for the formation
of micro loops and DNA condensation. In the WLC
measurement, DNA was under tension during most of
the time, thus loop formation was suppressed, resulting
in a basically invariable contour length. In addition, for
a short DNA (comparable to its persistence length), it is
diﬃcult to bend severely, thus is unable to form the
Figure 10. Proposed model for DNA shortening by cisplatin. Both di- and mono-adducts are formed. Due to the thermal ﬂuctuation, micro-loops
might occur through long-distance crosslinks. Then further distant crosslinks make the DNA condense to a collection of aggregates, and ﬁnally, the
DNA is compacted to a globule.
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previous works (38). We assume the formation of micro-
loop structures to be an important property for cisplatin–
DNA interaction with drug concentration of tens of
micromoles per liter and an incubation time of about
12h. Previously, it was generally believed that cisplatin
modiﬁed the DNA structures through intrastrand and
interstrand crosslinks between adjacent bases, our present
study further shows that distant crosslinks should also
play important roles in the drug–DNA interaction.
Our AFM imaging experiments with Pt(dach)Cl2 sug-
gest that oxaliplatin interacts with DNA in a similar way
as cisplatin. Besides oxaliplatin, there are also several
other platinum anti-cancer drugs that resemble cisplatin
in structure, such as carboplatin (45), JM118 (46) and
ZD0473 (47). They all bind to double helix, make intras-
trand and interstrand crosslinks, and distort DNA
towards the major groove in a similar manner. Based on
the studies of cisplatin and oxaliplatin, it is reasonable to
think that these similar platinum anti-cancer drugs modify
DNA structures in the same two-mode manner: (i) ﬁrst,
the drug induces interstrand or intrastrand crosslinks of
adjacent bases, making DNA more ﬂexible. Thus, in the
single molecule analysis using a magnetic tweezers, DNA
exhibits a decreased persistence length, and in AFM ima-
ging DNA shows a lot of local kinks. (ii) Then, the drug
induces formation of loops through crosslinks of distant
nucleotides brought together by DNA thermal ﬂuctua-
tion. At low drug concentrations, DNA exhibits a lot of
micro loops, while at extremely high drug concentrations,
the structures with micro loops will be further crosslinked
to form collection of large aggregates and ﬁnally the DNA
is condensed to a compact globule.
CONCLUSIONS
Mechanical properties of single   DNA molecules in the
presence of the anti-cancer drug cisplatin were investi-
gated by a magnetic tweezers. Compared with free  
DNA, the modiﬁed DNA was more ﬂexible, with its per-
sistence length decreased from  52 to  15nm. This beha-
vior is in agreement with the previously known binding
mode of cisplatin: forming intrastrand and interstrand
crosslinks and distorting the double helix towards the
major groove. The permanent static bending causes a
decrease of the WLC persistence length. AFM imaging
of   DNA treated by cisplatin of the same concentration
revealed more directly the curled structure of DNA with a
lot of local kinks. Besides, AFM imaging also showed that
the contour length of DNA was not aﬀected obviously by
cisplatin.
Importantly, we have found another behavior of cispla-
tin–DNA interaction: the formation of loop structures
due to DNA thermal ﬂuctuation and then DNA conden-
sation. In the single molecule experiments using the mag-
netic tweezers, the extension of DNA decreased rapidly
upon addition of a high concentration cisplatin. The
condensed DNA was unable to be stretched back to its
contour length even under a high force (20 pN). AFM
scanning revealed the processes of DNA condensation.
First, micro-loops with a size of  20nm appeared,
caused by crosslinks of mono-adducts with distant binding
sites due to DNA thermal ﬂuctuation as well as a reduced
persistence length. Then large aggregates were formed.
Finally DNA was condensed into a large compact globule.
Pt(dach)Cl2 was also analyzed by AFM imaging. Our
experiments reveal that Pt(dach)Cl2 (or oxaliplatin) makes
DNA ﬂexible and induces DNA loop structures in the
same manner as cisplatin, though a little weaker.
We think the occurrence of loop structures may be an
important feature of DNA modiﬁcation by this kind of
platinum anti-cancer drugs. The present study should be
useful for further understanding of the biological function
of the platinum anti-cancer drugs and for the design of
new drugs in the future.
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